683 related articles for article (PubMed ID: 12525438)
1. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
[TBL] [Abstract][Full Text] [Related]
2. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
4. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.
Hohmann FP; Laven JS; de Jong FH; Fauser BC
Eur J Endocrinol; 2005 Mar; 152(3):395-401. PubMed ID: 15757856
[TBL] [Abstract][Full Text] [Related]
5. Early follicle development alters the relationship between antral follicle counts and inhibin B and follicle-stimulating hormone levels on cycle day 3.
Grynberg M; Feyereisen E; Scheffer JB; Koutroubis P; Frydman R; Fanchin R
Fertil Steril; 2010 Feb; 93(3):894-9. PubMed ID: 19061996
[TBL] [Abstract][Full Text] [Related]
6. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE
Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of some ovarian reserve tests in poor responders.
Vladimirov IK; Tacheva DM; Kalinov KB; Ivanova AV; Blagoeva VD
Arch Gynecol Obstet; 2005 Jun; 272(1):74-9. PubMed ID: 15660265
[TBL] [Abstract][Full Text] [Related]
8. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
[TBL] [Abstract][Full Text] [Related]
10. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer.
Lockwood GM; Muttukrishna S; Groome NP; Knight PG; Ledger WL
Clin Endocrinol (Oxf); 1996 Dec; 45(6):741-8. PubMed ID: 9039341
[TBL] [Abstract][Full Text] [Related]
11. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age.
Robertson DM; Lee CH; Baerwald A
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00172. PubMed ID: 33855196
[TBL] [Abstract][Full Text] [Related]
12. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
Welt CK; Martin KA; Taylor AE; Lambert-Messerlian GM; Crowley WF; Smith JA; Schoenfeld DA; Hall JE
J Clin Endocrinol Metab; 1997 Aug; 82(8):2645-52. PubMed ID: 9253348
[TBL] [Abstract][Full Text] [Related]
13. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
[TBL] [Abstract][Full Text] [Related]
14. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
Ng EH; Chan CC; Tang OS; Ho PC
Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
[TBL] [Abstract][Full Text] [Related]
15. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
Anderson RA; Groome NP; Baird DT
Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
[TBL] [Abstract][Full Text] [Related]
16. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone.
Eldar-Geva T; Robertson DM; Cahir N; Groome N; Gabbe MP; Maclachlan V; Healy DL
J Clin Endocrinol Metab; 2000 Feb; 85(2):607-13. PubMed ID: 10690863
[TBL] [Abstract][Full Text] [Related]
18. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve.
Hendriks DJ; Broekmans FJ; Bancsi LF; de Jong FH; Looman CW; Te Velde ER
Hum Reprod; 2005 Jan; 20(1):163-9. PubMed ID: 15471926
[TBL] [Abstract][Full Text] [Related]
19. Circulating bioactive follicle stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle.
Reddi K; Wickings EJ; McNeilly AS; Baird DT; Hillier SG
Clin Endocrinol (Oxf); 1990 Oct; 33(4):547-57. PubMed ID: 2121399
[TBL] [Abstract][Full Text] [Related]
20. Cycle and hormone changes during perimenopause: the key role of ovarian function.
Burger HG; Hale GE; Dennerstein L; Robertson DM
Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
